Chengdu Easton Biopharmaceuticals Co Ltd (688513) — Cash Flow Quality Index
Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a Cash Flow Quality Index of 0.73x as of September 2025. Operating cash flow of CN¥61.35 Million is below net income of CN¥83.59 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore 688513 total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Chengdu Easton Biopharmaceuticals Co Ltd Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Chengdu Easton Biopharmaceuticals Co Ltd across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Chengdu Easton Biopharmaceuticals Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Chengdu Easton Biopharmaceuticals Co Ltd (2013–2025)
Year-by-year earnings quality comparison for Chengdu Easton Biopharmaceuticals Co Ltd. For live market cap and the full company financial profile, see Chengdu Easton Biopharmaceuticals Co Ltd stock valuation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.94x | CN¥264.94 Million | CN¥283.25 Million | ▼ -15.3% |
| 2024 | 1.10x | CN¥263.24 Million | CN¥238.23 Million | ▼ -9.0% |
| 2023 | 1.21x | CN¥275.25 Million | CN¥226.57 Million | ▲ +97.1% |
| 2022 | 0.62x | CN¥151.94 Million | CN¥246.52 Million | ▼ -2.9% |
| 2021 | 0.64x | CN¥147.60 Million | CN¥232.43 Million | ▼ -27.7% |
| 2020 | 0.88x | CN¥156.52 Million | CN¥178.16 Million | ▼ -32.7% |
| 2019 | 1.31x | CN¥141.83 Million | CN¥108.61 Million | ▲ +5.7% |
| 2018 | 1.24x | CN¥166.79 Million | CN¥135.02 Million | ▼ -7.2% |
| 2017 | 1.33x | CN¥85.70 Million | CN¥64.37 Million | ▼ -28.0% |
| 2016 | 1.85x | CN¥106.06 Million | CN¥57.32 Million | ▲ +37.7% |
| 2015 | 1.34x | CN¥50.57 Million | CN¥37.62 Million | ▼ -15.9% |
| 2014 | 1.60x | CN¥46.71 Million | CN¥29.23 Million | ▼ -16.3% |
| 2013 | 1.91x | CN¥28.12 Million | CN¥14.73 Million | — |